Noramco, LLC
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 500 Swedes Landing Road, Wilmington, Delaware (DE) 19801, United States (USA)
- Operations here
- api manufactureparticle size reductionrepack
- FDA identifiers
- FEI 2522445 · DUNS 166506142
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2025-10-15
- NAIDrug Quality Assurance2022-11-18
- NAIDrug Quality Assurance2019-02-21
- VAIDrug Quality Assurance2017-11-17
- NAIDrug Quality Assurance2016-01-21
- NAIDrug Quality Assurance2014-11-13
- NAIDrug Quality Assurance2012-04-27
- VAIDrug Quality Assurance2010-08-02
Drugs this plant is listed as making
2 distinct drugs across 7 products name this site in their FDA label.
- Amphetamine SulfateAurolife Pharma, LLC
- morphine sulfatein shortageSun Pharmaceutical Industries, Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.